3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 2
1
Status
Recruiting
3
Active not recruiting
2
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Carcinoma, Hepatocellular
28
Carcinoma, Non-Small-Cell Lung
22
Lung Neoplasms
17
Cholangiocarcinoma
13
Biliary Tract Neoplasms
13
Small Cell Lung Carcinoma
12
Triple Negative Breast Neoplasms
8
Breast Neoplasms
8
Neoplasms
6
Neoplasm Metastasis
5
Liver Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Pancreatic Neoplasms
4
Carcinoma
4
Non-Muscle Invasive Bladder Neoplasms
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Pathologic Complete Response
2
Ovarian Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Bile Duct Neoplasms
2
Advanced Biliary Tract Cancer
2
Adenocarcinoma of Lung
2
Adenocarcinoma
2
Vaccinia
1
SCLC, Limited Stage
1
Resectable Intrahepatic Cholangiocarcinoma
1
Interventions
Gemcitabine
9
Docetaxel
5
Mitomycin
4
erdafitinib
3
durvalumab
3
Cystoscopy
3
disitamab vedotin
2
BCG Vaccine
2
5-aminolevulinic acid hexyl ester
2
tremelimumab
1
tislelizumab
1
monalizumab
1
dodecyl maltoside
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Therapeutic Uses
1
Surveys and Questionnaires
1
Saline Solution
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Monatide (IMS 3015)
1
Mitozytrex
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Laser Therapy
1
Hyaluronic Acid
1
House Calls
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Non-Muscle Invasive Bladder Neoplasms
×
durvalumab
×
Clear all
NCT03317158
2026-04-15
ADAPT-BLADDER
Hoosier Cancer Research Network
Phase 1/2
Recruiting
55 enrolled
NCT06503614
2026-04-08
ENHANCE
Hoosier Cancer Research Network
Phase 2
Recruiting
60 enrolled
NCT04106115
2024-12-04
DURANCE
University College, London
Phase 1/2
Recruiting
64 enrolled